François Guillonneau

Dr. François Guillonneau

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
PHPauline Herviou
Pauline Herviou
MBMorgane Le Bras
Morgane Le Bras
LDLeïla Dumas
Leïla Dumas
CHCorinne Hieblot
Corinne Hieblot
JGJulia Gilhodes
Julia Gilhodes
SMStefania Millevoi
Stefania Millevoi
RNA G-quadruplexes (RG4s) are four-stranded structures known to control mRNA translation of cancer relevant genes. RG4 formation is pervasive in vitro but not in cellulo, indicating the existence of poorly characterized molecular machinery that remodels RG4s and maintains them unfolded. Here, we performed a quantitative proteomic screen to identify cytosolic proteins that interact with a canonical RG4 in its folded and unfolded conformation. Our results identified hnRNP H/F as important components of the cytoplasmic machinery modulating the structural integrity of RG4s, revealed their function in RG4-mediated translation and uncovered the underlying molecular mechanism impacting the cellular stress response linked to the outcome of glioblastoma.

7 January 2021 in Blood
Verified
Journal Article
Closed access
SGSalomé Le Goff
Salomé Le Goff
IBIsmael Boussaid
Ismael Boussaid
CFCelia Floquet
Celia Floquet
ARAnna Raimbault
Anna Raimbault
IHIsabelle Hatin
Isabelle Hatin
MFMichaela Fontenay
Michaela Fontenay
The role of ribosome biogenesis in erythroid development is supported by the recognition of erythroid defects in ribosomopathies in both Diamond-Blackfan anemia and 5q− syndrome. Whether ribosome biogenesis exerts a regulatory function on normal erythroid development is still unknown. In the present study, a detailed characterization of ribosome biogenesis dynamics during human and murine erythropoiesis showed that ribosome biogenesis is abruptly interrupted by the decline in ribosomal DNA transcription and the collapse of ribosomal protein neosynthesis. Its premature arrest by the RNA Pol I inhibitor CX-5461 targeted the proliferation of immature erythroblasts. p53 was activated spontaneously or in response to CX-5461, concomitant to ribosome biogenesis arrest, and drove a transcriptional program in which genes involved in cell cycle–arrested, negative regulation of apoptosis, and DNA damage response were upregulated. RNA Pol I transcriptional stress resulted in nucleolar disruption and activation of the ATR-CHK1-p53 pathway. Our results imply that the timing of ribosome biogenesis extinction and p53 activation is crucial for erythroid development. In ribosomopathies in which ribosome availability is altered by unbalanced production of ribosomal proteins, the threshold downregulation of ribosome biogenesis could be prematurely reached and, together with pathological p53 activation, prevents a normal expansion of erythroid progenitors.

10 July 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SBSabrina Bondu
Sabrina Bondu
AAAnne-Sophie Alary
Anne-Sophie Alary
CLCarine Lefèvre
Carine Lefèvre
AHAlexandre Houy
Alexandre Houy
GJGrace Jung
Grace Jung
MFMichaela Fontenay
Michaela Fontenay
A variant erythroferrone contributes to hepcidin modulation and systemic iron accumulation in patients with SF3B1 -mutated myelodysplastic syndrome.

13 July 2020 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
MHMyriam Hormi
Myriam Hormi
RBRudy Birsen
Rudy Birsen
MBMaya Belhadj
Maya Belhadj
THTony Huynh
Tony Huynh
LALilia Cantero Aguilar
Lilia Cantero Aguilar
Nicolas ChapuisNicolas Chapuis
Nicolas Chapuis

25 February 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
SMSara Mouasni
Sara Mouasni
VGVirginie Gonzalez
Virginie Gonzalez
ASAlain Schmitt
Alain Schmitt
EBEvangeline Bennana
Evangeline Bennana
FGFrançois Guillonneau
François Guillonneau
LTLéa Tourneur
Léa Tourneur
Fas-associated death domain (FADD) is a key adaptor molecule involved in numerous physiological processes including cell death, proliferation, innate immunity and inflammation. Therefore, changes in FADD expression have dramatic cellular consequences. In mice and humans, FADD regulation can occur through protein secretion. However, the molecular mechanisms accounting for human FADD secretion were still unknown. Here we report that canonical, non-canonical, but not alternative, NLRP3 inflammasome activation in human monocytes/macrophages induced FADD secretion. NLRP3 inflammasome activation by the bacterial toxin nigericin led to the proinflammatory interleukin-1β (IL-1β) release and to the induction of cell death by pyroptosis. However, we showed that FADD secretion could occur in absence of increased IL-1β release and pyroptosis and, reciprocally, that IL-1β release and pyroptosis could occur in absence of FADD secretion. Especially, FADD, but not IL-1β, secretion following NLRP3 inflammasome activation required extracellular glucose. Thus, FADD secretion was an active process distinct from unspecific release of proteins during pyroptosis. This FADD secretion process required K+ efflux, NLRP3 sensor, ASC adaptor and CASPASE-1 molecule. Moreover, we identified FADD as a leaderless protein unconventionally secreted through microvesicle shedding, but not exosome release. Finally, we established human soluble FADD as a new marker of joint inflammation in gout and rheumatoid arthritis, two rheumatic diseases involving the NLRP3 inflammasome. Whether soluble FADD could be an actor in these diseases remains to be determined. Nevertheless, our results advance our understanding of the mechanisms contributing to the regulation of the FADD protein expression in human cells.

13 April 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
EGEmilie-Fleur GAUTIER
Emilie-Fleur GAUTIER
MLMarjorie Leduc
Marjorie Leduc
MLMeriem Ladli
Meriem Ladli
VSVincent P. Schulz
Vincent P. Schulz
CLCarine Lefèvre
Carine Lefèvre
PMPatrick Mayeux
Patrick Mayeux
Murine-based cellular models have provided and continue to provide many useful insights into the fundamental mechanisms of erythropoiesis, as well as insights into the pathophysiology of inherited and acquired red cell disorders. Although detailed information on many aspects of these cell models is available, comprehensive proteomic data are lacking. This is a critical knowledge gap, as proteins are effectors of most biologic processes. To address this critical unmet need, proteomes of the murine cell lines Friend erythroleukemia (MEL), GATA1 erythroid (G1ER), and embryonic stem cell–derived erythroid progenitor (MEDEP) and proteomes of cultured murine marrow–derived erythroblasts at different stages of terminal erythroid differentiation were analyzed. The proteomes of MEDEP cells and primary murine erythroid cells were most similar, whereas those of MEL and G1ER cells were more distantly related. We demonstrated that the overall cellular content of histones does not decrease during terminal differentiation, despite strong chromatin condensation. Comparison of murine and human proteomes throughout terminal erythroid differentiation revealed that many noted transcriptomic changes were significantly dampened at the proteome level, especially at the end of the terminal differentiation process. Analysis of the early events associated with induction of terminal differentiation in MEDEP cells revealed divergent alterations in associated transcriptomes and proteomes. These proteomic data are powerful and valuable tools for the study of fundamental mechanisms of normal and disordered erythropoiesis and will be of broad interest to a wide range of investigators for making the appropriate choice of various cell lines to study inherited and acquired diseases of the erythrocyte.